MetLife Investment Management’s Revolution Medicines RVMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$271K	Sell	2,788 -750	-21%	-$75.7K	﹤0.01%	2069
2025 Q4	$282K	Buy	3,538 +648	+22%	+$42.5K	﹤0.01%	2101
2025 Q3	$135K	Buy	2,890 +3	+0.1%	+$117	﹤0.01%	2518
2025 Q2	$106K	Sell	2,887 -95,999	-97%	-$3.69M	﹤0.01%	2513
2025 Q1	$3.5M	Sell	98,886 -1,443	-1%	-$58.6K	0.02%	792
2024 Q4	$4.39M	Buy	100,329 +13,918	+16%	+$702K	0.02%	636
2024 Q3	$3.92M	Sell	86,411 -1,501	-2%	-$65.4K	0.02%	669
2024 Q2	$3.41M	Buy	87,912 +16,705	+23%	+$624K	0.02%	709
2024 Q1	$2.3M	Sell	71,207 -4,190	-6%	-$124K	0.02%	898
2023 Q4	$2.16M	Buy	75,397 +21,936	+41%	+$527K	0.02%	919
2023 Q3	$1.48M	Hold	53,461	–	–	0.01%	1035
2023 Q2	$1.43M	Buy	53,461 +7,885	+17%	+$193K	0.01%	1075
2023 Q1	$987K	Buy	45,576 +6,059	+15%	+$149K	0.01%	1228
2022 Q4	$941K	Hold	39,517	–	–	0.01%	1251
2022 Q3	$779K	Buy	39,517 +5,261	+15%	+$116K	0.01%	1319
2022 Q2	$668K	Hold	34,256	–	–	0.01%	1469
2022 Q1	$874K	Buy	34,256 +12,643	+58%	+$275K	0.01%	1415
2021 Q4	$544K	Hold	21,613	–	–	﹤0.01%	1458
2021 Q3	$595K	Hold	21,613	–	–	0.01%	1428
2021 Q2	$686K	Buy	21,613 +4,956	+30%	+$173K	0.01%	1388
2021 Q1	$764K	Hold	16,657	–	–	0.01%	1279
2020 Q4	$659K	Hold	16,657	–	–	0.01%	1335
2020 Q3	$580K	Buy	16,657 +9,645	+138%	+$267K	0.01%	1296
2020 Q2	$221K	Hold	7,012	–	–	﹤0.01%	1850
2020 Q1	$154K	Buy	+7,012	New	+$194K	﹤0.01%	1838